LeMaitre Vascular, Inc. (LMAT) is highlighted as a strong growth stock, currently recommended by Zacks Investment Research due to its robust financial performance. The company has a projected earnings per share (EPS) growth rate of 17.2% for 2023, surpassing the industry average of 11.4%. Additionally, LeMaitre boasts a year-over-year cash flow growth rate of 35.1%, significantly higher than the industry average of 1.2%.
Recent upward revisions in earnings estimates have also bolstered LeMaitre’s appeal; the Zacks Consensus Estimate for the current year has increased by 5.6% over the past month. LeMaitre holds a Growth Score of B and a Zacks Rank of 2 (Buy), suggesting it has strong potential for growth and may outperform its peers.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
